Other Clinical Trial - Lybrido for Female Sexual Dysfunction

Status Completed

Clinical Trial Summary

The Lybrido study is a double-blind, randomized, placebo-controlled study with a 4-week baseline establishment period, 16 week treatment period and a follow up period for a total of 26 weeks on study. Subjects are randomly to one of seven treatment arms. The study investigates the effective dose of Lybrido in increasing the number of satisfactory sexual episodes in the domestic setting in 210 healthy female subjects with hypoactive sexual desire disorder and low sensitivity for sexual cues (30 subjects per group).

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Hypoactive Sexual Desire Disorder
Sexual Dysfunctions, Psychological

Clinical Trial Details

NCT number	NCT01432665
Study type	Interventional
Source	Emotional Brain NY Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	September 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02430987` - Low Sexual Desire and Metabolic Syndrome	N/A
Terminated	`NCT00551785` - Surveillance Study of Women Taking Intrinsa®	Phase 4
Completed	`NCT03232801` - A Mindfulness-based Intervention for Older Women With Low Sexual Desire	N/A
Recruiting	`NCT04179734` - Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder	Phase 4
Active, not recruiting	`NCT02770768` - Effects of Flibanserin on the Pre- and Post-menopausal Female Brain	N/A
Completed	`NCT01235754` - Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)	Phase 3
Completed	`NCT03287232` - Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)	Phase 3
Completed	`NCT00384046` - Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen	Phase 3
Completed	`NCT00331123` - Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido	Phase 3
Recruiting	`NCT04943068` - A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal)	Phase 3
Completed	`NCT03463707` - BP101 for Adults With Female Sexual Dysfunction	Phase 3
Completed	`NCT01208038` - Testosterone Patch's Effects on the Cardiovascular System and Libido	Phase 4
Completed	`NCT00657501` - Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women	Phase 3
Completed	`NCT04336891` - Effect of Testosterone Treatment on Clitoral Arteries' Hemodynamic Parameters.
Completed	`NCT01382719` - Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder	Phase 2
Recruiting	`NCT00916396` - Dehydroepiandrosterone (DHEA) Treatment in Women and Men Experiencing Hypoactive Sexual Desire Disorder	N/A
Completed	`NCT00338312` - Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido	Phase 3
Completed	`NCT00331214` - Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido	Phase 3
Completed	`NCT00034021` - Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction	Phase 2
Recruiting	`NCT02968342` - Role of Progesterone in Hypoactive Sexual Desire Disorder in Menopausal Women	Phase 4